Dan Browne

Advisory Board

Dan Browne, a member of the Advisory Committee for Galderma, has more than 30 years of entrepreneurial and executive leadership experience in the healthcare industry. He has led the development of multiple innovative products that are leaders in their category, as well as critical business development and partnership activities. He is the Co-Founder and former President & Chief Executive Officer of Revance Therapeutics, Inc. He brought the company from early-stage incubator in 2002 to a highly successful IPO in 2014. During the course of his tenure, he led clinical, regulatory/quality, finance and commercial operations. Prior roles include President & CEO of Neomend, President & CEO of Prograft Medical, and Business Leader at WL Gore & Associates, Inc.

Since 2020, Dan has been a board member to AVAVA, Fount Bio, and Rythera Therapeutics. Dan holds an MBA from Pepperdine Graziadio Business School.